Novartis’ Managing Director of Oncology (ANZ/NZ) joins Medlab Clinical board

Date:  2021-03-23
Author:   Medlab
Novartis Managing Director of Oncology (ANZ/NZ) appointed to board of Medlab Clinical

The managing director of Novartis Oncology for Australia and New Zealand, Cheryl Maley, has been appointed to the board of Medlab Clinical as a Non-Executive Director. Mrs Maley joins the board with strong pharmaceutical experience including over 20 years in roles across Sales, Marketing, Business Development, Commercial Excellence, Patient Access and General Management.

Mrs Maley is a knowledgeable and multi-functional leader with a proven track record in accelerating and driving long-term strategic growth through innovation, partnering and steering organisational development and projects. Cheryl’s global focus, especially within her US (Chicago-based for three years) and Asia tenure (Philippines-based for three years) in seeing products through to regulatory approval and knowledge of the oncology market, will be invaluable as we embark on the next stage of our journey.

Read about our market release available at BiotechDispatch

Our recent ASX announcements can be found here

Learn more about our Leadership team here

COMMENTS 0

Tell us what you think login to share your thoughts.

ABOUT THE AUTHOR

Medlab Author
Medlab Author
Medlab

Medlab in-house Editor.